Joint Filing Agreement
Exhibit 99.2
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Catalyst Biosciences, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: July 23, 2019
| CCUR HOLDINGS, INC. | |||
| By: |
/s/ Xxxxx Xxxx, Xx | ||
| Name: | Xxxxx Xxxx, Xx. | ||
| Title: | CEO, President and Executive Chairman | ||
| JDS1, LLC | |||
| By: |
/s/ Xxxxxx Xxxxxx | ||
| Name: | Xxxxxx Xxxxxx | ||
| Title: | Managing Member | ||
| /s/ Xxxxx Xxxx, Xx. | |
| Xxxxx Xxxx, XX. |
|
/s/ Xxxxx X. Xxxx | |
| Xxxxx X. Xxxx |
| /s/ Xxxxxx Xxxxxx | |
| Xxxxxx Xxxxxx |
